ExploreWatchlistsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Accounts receivable, net

WEST PHARMACEUTICAL SERVICES INC (WST)

Market cap
$18.4B
P/E ratio
37.5x
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Dec 31, 2025574+3.96%
Dec 31, 2024553+7.91%
Dec 31, 2023512+0.91%
Dec 31, 2022507+3.76%
Dec 31, 2021489+26.91%
Dec 31, 2020385+20.67%
Dec 31, 2019319+10.79%
Dec 31, 2018288+13.82%
Dec 31, 2017253+26.28%
Dec 31, 2016201+10.53%
Dec 31, 2015181+1.34%
Dec 31, 2014179-3.61%
Dec 31, 2013186+6.11%
Dec 31, 2012175+38.45%
Dec 31, 2010126

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat